Ignite Creation Date:
2025-12-25 @ 5:03 AM
Ignite Modification Date:
2026-01-26 @ 5:25 AM
Study NCT ID:
NCT03468218
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2025-02-05
First Post:
2018-03-10
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Pembrolizumab & Cabozantinib in Patients With Head and Neck Squamous Cell Cancer
Sponsor:
Emory University
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
IRB00100269
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None